The epidemic of the 2019 novel coronavirus (severe acute respiratory syndrome coronavirus 2 – SARSCoV-2), which was first identified in Wuhan, a cityin the Hubei province in China, is being exported to a growing number of countries. Early efforts were focused on describing the clinical course, counting severe cases, and treating the disease1. Covid-19 has
The global coronavirus disease 2019 (COVID-19) has presented major challenges for clinical laboratories, from initial diagnosis to patient monitoring and treatment. As I write this editorial, many laboratory specialists, technologists, and trainees are selflessly and tirelessly standing on the front lines of the battle against COVID-19. This is happening at hospital laboratories and at private
Namibia Central Pathology.
Namibia Central Pathology (NCP) is a well-established Private Medical Laboratory, providing Pathology ...